The Challenge of Recurrent Basal Cell Carcinoma in the Presence of Comorbidities

Hematology-Oncology
Curriculum:
Diagnosis and Treatment of Basal Cell Carcinomas
Credits:
0.75 ANCC Contact Hours 0.75 CA-BRN Credit(s) 0.75 AMA PRA Category 1 Credit(s)™
Launch Date:
January 16, 2014
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Dermatologic Oncologists, Dermatologists, Oncologists

Relevant Terms:

Basal Cell Carcinoma

Timothy Wang, MD

Timothy Wang, MD
Associate Professor, Department of Dermatology
Director, Mohs Surgery Program
Director, Cutaneous Skin Oncology Program
Johns Hopkins Medicine
Baltimore, MD

Timothy Wang, MD is Associate Professor, Department of Dermatology as well as Director of the Mohs Surgery and of the Cutaneous Skin Oncology Programs at Johns Hopkins University. He completed his training in dermatology and Mohs surgery at the University of Michigan. His clinical interests are in Mohs micrographic surgery and melanoma.

Howard Sofen, MD

Howard Sofen, MD
Medical Director
Dermatology Research Associates
Los Angeles, CA

Howard Sofen, MD is a Board Certified Dermatologist who has been serving the Los Angeles area for nearly 30 years. Dr. Sofen is a fellow of the American Academy of Dermatology and a Diplomate of the American Board of Dermatology. He has serves as the Assistant Clinical Professor of Medicine at the UCLA School of Medicine and is currently serving as the Dermatology Division Chief at UCLA’s Olive View Medical Center since 1985.

Krista M. Rubin, MS, RN, FNP, BC

Krista M. Rubin, MS, RN, FNP, BC
Nurse Practitioner
Massachusetts General Hospital
Boston, MA

Krista M. Rubin, MS, RN, FNP, BC is a nurse practitioner at Massachusetts General Hospital in Boston. She is an active member of the Oncology Nursing Society (ONS), the ONS Nurse Practitioner Special Interest Group, and the Boston Chapter of ONS. She is the chair of the Skin Cancer Committee of the Dermatology Nursing Society and a member of the American Society of Clinical Oncology.
1. Explain the role of the hedgehog pathway in the pathogenesis of BCC, as well as the significance and safety profiles of new and investigational smoothened (SMO) antagonists for treatment of advanced BCC
2. Identify advantages and disadvantages of the major choices for treating locally advanced and metastatic BCC and use this information to more appropriately treat patients in the next month

Instructions on How to Receive Credit
  • Participants must review the materials on accreditation information, target audience, learning objectives, and disclosure information.
  • Complete the entire activity, pre/post-test and evaluation.
  • After passing the post-test, print out your electronic CE certificate.
  • In order to successfully complete this activity learners must achieve a minimum of 65% on the post-test.

This activity is supported by an educational grant from Genentech.

This activity is sponsored by the Institute for Continuing Healthcare Education.

Release Date: January 16, 2014
Expiration Date: January 16, 2015

 
Accreditation Statements
Physicians
The Institute for Continuing Healthcare Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
The Institute for Continuing Healthcare Education designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 
  
Nurses
Institute for Continuing Healthcare Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity offers 0.75 contact hours to participating nurses. This credit may be applied toward licensure requirements in those states that recognize American Nurses Credentialing Center's Commission on Accreditation (ANCC-COA) accredited providers.

Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA. 
 
Institute for Continuing Healthcare Education is approved by the California Board of Registered Nursing, Provider Number 13313. The Institute for Continuing Healthcare Education approves this activity for 0.75 contact hours.
 
Disclosure
It is the policy of the Institute for Continuing Healthcare Education (the Institute) that the education presented within Institute-provided, CE-certified activities be unbiased and based upon scientific evidence. To help participants make judgments about the presence of bias, the Institute provides information that planners, teachers, authors, developers, and activity managers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this educational activity. Any relationships that an individual may have with commercial entities have been disclosed and reviewed, and any potential conflicts have been resolved.
 
Relationships are abbreviated as follows: E, Educational Planning Committee; G, Grant/research support recipient; A, Advisor/review panel member/educational planning committee; C, Consultant/Independent Contractor; SS, Stock shareholder; SB, Speaker bureau; PE, Promotional Event Talks; H, Honoraria; O, Other.

Educational Planning Committee

Timothy Wang, MD

Associate Professor, Department of Dermatology
Johns Hopkins Medicine
Baltimore, MD

Dr. Wang has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of the activity.

Howard Sofen, MD
Medical Director
Dermatology Research Associates
Los Angeles, CA

Dr. Sofen has disclosed the following relevant financial relationships that have occured in the last 12 months: Genentech/A, G, SB, PE.

Krista Rubin, MS, RN, FNP, BC
Nurse Practitioner
Massachusetts General Hospital
Boston, MA
 
Ms. Rubin has disclosed the following relevant financial relationships that have occured in the last 12 months: Genentech, Merck/A.

Content Freelancer
Laura Ninger, ELS, Medical Writer
Ninger Medical Communications, LLC
Rutherford, NJ
 
Ms. Ninger has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.

Content Peer Reviewer
Natasha Mesinkovska, MD, PhD
Cleveland Clinic
Cleveland, OH
 
Dr. Mesinkovska has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.

Activity Development and Management Team
Cathy Pagano, CCMEP; Allison A. Muller, Pharm.D, D.ABAT; Scott Kober, MBA, CCMEP; April Reynolds, MS, ELS; Sandra Davidson
; and Megan Small are employees of the Institute and have no relationships to disclose.
 
Off-label Product Disclosure
This educational activity includes discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
 
COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 5.0+ for Mac OSX 10.5 and above

For video playback, install the latest version of Flash or Quicktime.
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above



 
 For additional technical support, please send an email to msmall@iche.edu.
 
General Disclosure and Copyright Statement
The opinions expressed in this publication are those of the participating faculty and not those of the Institute for Continuing Healthcare Education (the Institute), Genentech, or any manufacturers of products mentioned herein.

This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional regarding diagnostic and treatment options of a specific patient's medical condition. In no event will the Institute be responsible for any decision made or action taken based upon the information provided in this activity.

Participants are encouraged to consult the package insert for all products for updated information and changes regarding indications, dosages, and contraindications. This recommendation is particularly important for new or infrequently used products.

Copyright 2014. Institute for Continuing Healthcare Education (the Institute). All rights reserved. No part of this publication may be reproduced or transmitted in any other form or by any means electronic or mechanical—without first obtaining written permission from the Institute.

The Institute reserves the right to cancel or modify the activity content, faculty, and activities if necessary.